Powered By
80 items
2026-11-17
HORIBA, Ltd. provided dividend guidance for the Year Ending December 31, 2026. For the year, the company expects to pay year end dividend of JPY 210.00 per share, against JPY 210.00 per share paid a year ago.
2026-11-17
HORIBA, Ltd. revised consolidated earnings guidance for the full year ending December 31, 2026. For the full year, the company now expects net sales of JPY 392,500 million, operating income of JPY 73,000 million, net income attributable to HORIBA, Ltd.'s shareholders of JPY 51,500 million, and Net Income Attributable to HORIBA, Ltd.'s Shareholders per Share of JPY 1,225.56 as compared to previous guidance of net sales of JPY 382,000 million, operating income of JPY 70,000 million, net income attributable to HORIBA, Ltd.'s shareholders of JPY 50,000 million.
2026-10-30
HORIBA, Ltd., Q3 2026 Earnings Call, Nov 13, 2026
2026-10-14
HORIBA, Ltd. Presents at SEMICON Europa 2026, Nov-10-2026 . Venue: Trade Fair Center Messe München, München, Germany.
2026-10-10
HORIBA, Ltd. reported earnings results for the half year ended June 30, 2026. For the half year, the company reported sales was JPY 179,853 million. Net income was JPY 21,806 million. Basic earnings per share from continuing operations was JPY 519.15. Diluted earnings per share from continuing operations was JPY 516.8.
2026-10-06
HORIBA, Ltd. Presents at The Battery Show North America 2026, Oct-12-2026 . Venue: Huntington Place, Detroit, Michigan, United States.
2026-10-06
HORIBA, Ltd. Presents at FC3 Fuel Cell Conference Chemnitz 2026, Nov-10-2026 . Venue: Chemnitz, Germany.
2026-10-05
HORIBA, Ltd. Presents at Gulf Coast Conference 2026, Oct-12-2026 . Venue: Galveston, Texas, United States.
2026-09-28
Gulf Coast Conference, Gulf Coast Conference 2026, Oct 12, 2026 through Oct 15, 2026. Venue: Galveston, Texas, United States.
2026-09-23
HORIBA, Ltd. Presents at Carbon Capture Technology World EXPO 2026, Oct-20-2026 . Venue: Hamburg Messe, Hamburg, Germany.
2026-09-23
HORIBA, Ltd. Presents at AAPS PharmSci 360 2026, Oct-25-2026 . Venue: Ernest N. Morial Convention Center, New Orleans, Louisiana, United States.
2026-09-17
HORIBA, Ltd. Presents at SEMICON West 2026, Oct-13-2026 . Venue: Moscone Center, San Francisco, California, United States.
2026-09-04
HORIBA, Ltd. announced that they will report Q3, 2026 results on Nov 13, 2026
2026-08-27
On March 25, 2026, Oasis Management Company Ltd. commented on the outcome of HORIBA, Ltd.’s 2026 Annual General Meeting held on March 21, 2026. Oasis stated that while all company proposals were approved, Chairman Atsushi Horiba’s reappointment was approved with only 74.4% of votes cast in favor, a sharp decline from approximately 91.0% support the prior year. Oasis viewed this as a clear and serious warning to the management from its shareholders that the Board cannot and should not dismiss. Oasis also highlighted low approval rates for other directors, including newly-appointed CFO Hiroshi Koyama (81.6%), Director Dan Horiba (82.4%), Director George Gillespie (82.4%), and Outside Directors Fumihiko Matsuda and Tomoko Tanabe (86.7% each). Oasis stated that shareholders are demanding a truly independent and competent board to strictly scrutinize the Company’s management and intends to continue its engagement with HORIBA.
2026-08-13
HORIBA, Ltd. updated earnings guidance for the fiscal year 2028. For the year, the company now expects net sales of JPY 460.0 billion, operating income of JPY 90.0 billion, net income of JPY 62.0 billion as compared to net sales of JPY 450.0 billion, operating income of JPY 80.0 billion, net income of JPY 55.0 billion.
2026-08-12
Horiba, Ltd. announced dividend of JPY 150.00 per share for the second quarter ended June 30, 2026 against JPY 80.00 per share a year ago. Record date is June 30, 2026. Scheduled date of start of interim dividend payment: August 31, 2026.
2026-08-12
HORIBA, Ltd. expects to pay special dividend of JPY 190 per share and commemorative dividend of JPY 240 per share for the fiscal year ending December 31, 2026. The Company's shareholder return policy is targeting a dividend payout ratio at 30% of consolidated net income attributable to HORIBA Ltd.'s shareholders, while special dividend and share buybacks will be executed timely and properly, taking into account investment opportunities, cash flow situation and other factors. In May 2026, the Company's market capitalization exceeded JPY 1 trillion. The company liked to express its sincere gratitude to its shareholders and other stakeholders for their generous support, which has made this milestone possible. Accordingly, the company has decided to pay a commemorative dividend of JPY 240 per share, totaling approximately JPY 10 billion, in commemoration of the milestone of the Company's market capitalization exceeding JPY 1 trillion and to express its appreciation for its shareholders' continued support. In addition, considering the revised consolidated earnings forecasts for Fiscal Year 2026, the Company has amended the annual forecast for the ordinary dividend increasing by JPY 60 to JPY 360 per share.
2026-08-12
HORIBA, Ltd. revised consolidated earnings guidance for the full year ending December 31, 2026. For the full year, the company now expects net sales of JPY 382,000 million, operating income of JPY 70,000 million, net income attributable to HORIBA, Ltd.'s shareholders of JPY 50,000 million, and Net Income Attributable to HORIBA, Ltd.'s Shareholders per Share of JPY 1,189.87.
2026-08-08
HORIBA, Ltd. expected to report Q3 2026 results on November 13, 2026. This event was calculated by S&P Global (Created on August 8, 2026).
2026-08-07
HORIBA, Ltd., Board Meeting, Aug 07, 2026. Agenda: To consider to pay an interim dividend from retained earnings with a record date of June 30, 2026 and to revise its dividend forecast for FY2026, previously announced on May 14, 2026.
2026-08-05
HORIBA, Ltd. Presents at Semicon India 2026, Sep-17-2026 . Venue: Yashobhoomi, Hall 2, India International Convention & Expo Centre, New Delhi, India.
2026-07-24
American Association of Pharmaceutical Scientists, AAPS PharmSci 360 2026, Oct 25, 2026 through Oct 28, 2026. Venue: Ernest N. Morial Convention Center, New Orleans, Louisiana, United States.
2026-07-21
HORIBA, Ltd. Presents at ADLM Annual Meeting 2026, Jul-26-2026 . Venue: Anaheim Convention Center, Anaheim, California, United States.
2026-07-17
SEMI, MEITY’s limited, Semicon India 2026, Sep 17, 2026 through Sep 19, 2026. Venue: Yashobhoomi, Hall 2, India International Convention & Expo Centre, New Delhi, India.
2026-07-16
HORIBA, Ltd., Q2 2026 Earnings Call, Aug 10, 2026
2026-07-08
HORIBA, Ltd. Presents at 34th Congress of the International Society on Thrombosis and Haemostasis, Jul-11-2026 . Venue: Palais des Congrès de Paris, Paris, France.
2026-07-03
HORIBA, Ltd. Presents at SciX 2026, Oct-04-2026 . Venue: Nugget Casino Resort, Sparks, Nevada, United States.
2026-07-03
Federation of Analytical Chemistry and Spectroscopy Societies (FACSS), SciX 2026, Oct 04, 2026 through Oct 09, 2026. Venue: Nugget Casino Resort, Sparks, Nevada, United States.
2026-07-01
HORIBA, Ltd. Presents at THIESEL 2026, Sep-08-2026 . Venue: Valencia, Spain.
2026-07-01
Universitat Politècnica de València, CMT - Clean Mobility & Thermofluids, THIESEL 2026, Sep 08, 2026 through Sep 11, 2026. Venue: Valencia, Spain.
2026-06-27
HORIBA, Ltd. announced that they will report Q2, 2026 results on Aug 07, 2026
2026-06-25
The International Society On Thrombosis And Haemostasis Inc, 34th Congress of the International Society on Thrombosis and Haemostasis, Jul 11, 2026 through Jul 15, 2026. Venue: Palais des Congrès de Paris, Paris, France.
2026-06-17
HORIBA, Ltd. Presents at 34th International Materials Research Congress, Aug-16-2026 . Venue: Cancun, Mexico.
2026-06-17
Sociedad Mexicana de Materiales, Materials Research Society, 34th International Materials Research Congress, Aug 16, 2026 through Aug 20, 2026. Venue: Cancun, Mexico.
2026-06-16
FUJIFILM Corporation announced that it has co-developed a high-sensitivity inline Raman measurement system with HORIBA, Ltd. that enables continuous, real-time monitoring of component concentrations directly from bioreactor and process equipment during cell culture and purification in biopharmaceutical manufacturing. When this system is used to control purification processes in antibody drug manufacturing, antibody yield improves by approximately 10% compared with conventional UV-Vis-based process control methods. The system developed jointly by the two companies combines a high-sensitivity Raman spectrometer, a single-use probe with a superior optical throughput, and Fujifilm’s proprietary measurement algorithms to predict quality attributes. By integrating Fujifilm’s optical design technologies, cultivated through its imaging and optical device businesses, and its expertise in biopharmaceutical manufacturing in its Bio-CDMO business with HORIBA’s Raman spectroscopy technologies, known for their high sensitivity, precision, and stability, the companies have developed an inline Raman measurement system that achieves industry-leading sensitivity. This enables high-precision, real-time monitoring of changes in the composition of cell culture media and purification solutions. Going forward, the two companies will work together to verify the system towards real-world use. By improving manufacturing processes’ monitoring and advanced data analysis technologies, the system is intended to contribute to the stable manufacturing of high-quality biopharmaceuticals, including antibody drugs, and the reduction of manufacturing costs.
2026-06-12
HORIBA, Ltd. Presents at Singapore International Water Week 2026, Jun-16-2026 . Venue: Sands Expo and Convention Centre, Singapore.
2026-06-09
HORIBA, Ltd. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was JPY 84,529 million compared to JPY 71,877 million a year ago. Net income was JPY 8,656 million compared to JPY 8,113 million a year ago. Basic earnings per share from continuing operations was JPY 206.13 compared to JPY 193.39 a year ago. Diluted earnings per share from continuing operations was JPY 205.14 compared to JPY 192.4 a year ago.
2026-06-06
HORIBA, Ltd. revised consolidated earnings guidance for the first half and full year ending December 31, 2026. For the first half, the company now expects net sales of JPY 167,000 million, operating income of JPY 28,000 million, net income attributable to HORIBA, Ltd.'s shareholders of JPY 20,000 million, and Net Income Attributable to HORIBA, Ltd.'s Shareholders per share of JPY 476.24. For the full year, the company now expects net sales of JPY 373,000 million, operating income of JPY 68,000 million, net income attributable to HORIBA, Ltd.'s shareholders of JPY 48,500 million, and Net Income Attributable to HORIBA, Ltd.'s Shareholders per Share of JPY 1,154.88.
2026-05-15
HORIBA, Ltd. expected to report Q2 2026 results on August 7, 2026. This event was calculated by S&P Global (Created on May 15, 2026).
2026-05-11
HORIBA, Ltd. announced that they will report Q1, 2026 results on May 14, 2026
2026-05-09
HORIBA, Ltd. Presents at 10th International Conference on Tip-Enhanced Raman Spectroscopy, Jun-03-2026 . Venue: Zurich, Switzerland.
2026-05-09
HORIBA, Ltd. Presents at 249th ECS Meeting, May-24-2026 . Venue: Seattle, Washington, United States.
2026-05-09
HORIBA, Ltd. Presents at Canadian Societies for Chemistry and Chemical Engineering 2026 Conferences and Exhibition, May-24-2026 . Venue: Toronto, Ontario, Canada.
2026-05-09
HORIBA, Ltd. Presents at EuroBrake 2026, Jun-01-2026 . Venue: Mainz, Germany.
2026-05-09
International Federation Of Automotive Engineering Societies, EuroBrake 2026, Jun 01, 2026 through Jun 03, 2026. Venue: Mainz, Germany.
2026-05-09
Canadian Society For Chemistry, Canadian Societies for Chemistry and Chemical Engineering 2026 Conferences and Exhibition, May 24, 2026 through May 28, 2026. Venue: Toronto, Ontario, Canada.
2026-05-09
The Electrochemical Society Inc, 249th ECS Meeting, May 24, 2026 through May 28, 2026. Venue: Seattle, Washington, United States.
2026-05-09
Eidgenössische Technische Hochschule Zürich, 10th International Conference on Tip-Enhanced Raman Spectroscopy, Jun 03, 2026 through Jun 05, 2026. Venue: Zurich, Switzerland. The conference focuses on the latest developments in TERS, including advances in reliability, spatial resolution, enhancement techniques, and methodology. The scientific program features invited talks, industry presentations, and poster sessions, while also covering related technologies such as SNOM, TEPL, and AFM-IR.
2026-05-09
Informa Markets Limited, The Battery Show North America 2026, Oct 12, 2026 through Oct 15, 2026. Venue: Huntington Place, Detroit, Michigan, United States.
2026-05-08
Trans-Global Events Ltd., Carbon Capture Technology World EXPO 2026, Oct 20, 2026 through Oct 22, 2026. Venue: Hamburg Messe, Hamburg, Germany.
2026-04-25
SEMI, SEMICON Europa 2026, Nov 10, 2026 through Nov 13, 2026. Venue: Trade Fair Center Messe München, München, Germany.
2026-04-24
HORIBA, Ltd., Q1 2026 Earnings Call, May 14, 2026
2026-04-17
HORIBA, Ltd., Board Meeting, Apr 17, 2026. Agenda: To discuss disposal of treasury stock as a post-vesting restricted stock unit (RSU) grant system.
2026-04-16
HORIBA, Ltd. Presents at SEMICON SEA 2026, May-05-2026 . Venue: MITEC, Kuala Lumpur, Malaysia.
2026-04-14
HORIBA, Ltd. Presents at IFAT Munich 2026, May-04-2026 . Venue: Messe München, Munich, Bavaria, Germany.
2026-04-10
HORIBA, Ltd., ¥ 150., Cash Dividend, Jun-29-2026
2026-03-30
Messe München GmbH, IFAT Munich 2026, May 04, 2026 through May 07, 2026. Venue: Messe München, Munich, Bavaria, Germany.
2026-03-29
HORIBA, Ltd. Presents at ISEV Annual Meeting 2026, Apr-26-2026 .
2026-03-29
HORIBA, Ltd. Presents at MEORGA Bochum 2026, May-06-2026 . Venue: Bochum, Germany.
2026-03-29
Vogel Communications Group GmbH & Co.KG, MEORGA Bochum 2026, May 06, 2026. Venue: Bochum, Germany.
2026-03-29
International Society For Extracellular Vesicles Inc, ISEV Annual Meeting 2026, Apr 23, 2026 through Apr 26, 2026.
2026-03-28
HORIBA, Ltd. Presents at Hannover Messe 2026, Apr-20-2026 . Venue: Hannover Fairgrounds, 30521 Hannover, Hannover, Germany.
2026-03-28
HORIBA, Ltd. Presents at LabDays Stockholm 2026, Apr-15-2026 . Venue: ÄLvsjö, Sweden.
2026-03-28
J.B. Exhibitions Aps, LabDays Stockholm 2026, Apr 15, 2026 through Apr 16, 2026. Venue: ÄLvsjö, Sweden.
2026-03-24
HORIBA, Ltd. Presents at Lab Indonesia 2026, Apr-15-2026 . Venue: the Indonesia Convention Exhibition in BSD City, Indonesia.
2026-03-24
Informa Markets Limited, Lab Indonesia 2026, Apr 15, 2026 through Apr 17, 2026. Venue: the Indonesia Convention Exhibition in BSD City, Indonesia.
2026-03-16
Singapore International Water Week Pte Ltd., Singapore International Water Week 2026, Jun 16, 2026. Venue: Sands Expo and Convention Centre, Singapore.
2026-03-04
Association For Diagnostics & Laboratory Medicine, ADLM Annual Meeting 2026, Jul 26, 2026 through Jul 30, 2026. Venue: Anaheim Convention Center, Anaheim, California, United States.
2026-02-27
SEMI, SEMICON West 2026, Oct 13, 2026 through Oct 15, 2026. Venue: Moscone Center, San Francisco, California, United States.
2026-02-25
Deutsche Messe AG, Hannover Messe 2026, Apr 20, 2026 through Apr 24, 2026. Venue: Hannover Fairgrounds, 30521 Hannover, Hannover, Germany.
2026-02-21
HORIBA, Ltd. provided consolidated earnings guidance for the first half and full year of fiscal year ending December 31, 2026. For the first half, the company expects net sales of JPY 156,000 million, operating income of JPY 24,000 million, net income attributable to HORIBA Ltd.'s Shareholders of JPY 17,000 million and net income attributable to HORIBA Ltd.'s Shareholders per Share of JPY 404.80. For the full year, the company expects net sales of JPY 345,000 million, operating income of JPY 56,000 million, net income attributable to HORIBA Ltd.'s Shareholders of JPY 40,500 million and net income attributable to HORIBA Ltd.'s Shareholders per Share of JPY 964.38.
2026-02-21
HORIBA, Ltd. announced cash dividend for the fiscal year ended December 31, 2025 of JPY 210.00 per share compared to JPY 190.00 per share paid a year ago. Scheduled date to commence dividend payments is March 2, 2026. For the second quarter of fiscal year ending December 31, 2026, the company expects to pay dividend of JPY 150.00 per share as compared to JPY 80 per share a year ago. For the full year of fiscal year ending December 31, 2026, the company expects to pay dividend of JPY 340.00 per share as compared to JPY 210.00 per share paid a year ago.
2026-02-15
HORIBA, Ltd. reported earnings results for the full year ended December 31, 2025. For the full year, the company reported sales was JPY 333,081 million. Net income was JPY 37,090 million. Basic earnings per share from continuing operations was JPY 883.5. Diluted earnings per share from continuing operations was JPY 879.27.
2026-02-13
HORIBA, Ltd. expected to report Q1 2026 results on May 14, 2026. This event was calculated by S&P Global (Created on May 9, 2026).
2026-02-13
HORIBA, Ltd., ¥ 160., Cash Dividend, Dec-29-2025
2026-02-12
HORIBA, Ltd., Annual General Meeting, Mar 21, 2026, at 10:00 Tokyo Standard Time. Location: 6th floor, TECHNO PLAZA, HORIBA Techno Service, Co., Ltd. Head Office 18 Maegawara-cho, Kisshoin, Minami-ku, Kyoto-shi Japan Agenda: To consider the Business Report, the Consolidated Financial Statements, and the audit results of the Consolidated Financial Statements by the Accounting Auditor and the Audit & Supervisory Board for the 88th Fiscal Term; to consider the Non-Consolidated Financial Statements for the 88th Fiscal Term; to consider the election of nine Directors; and to discuss other matters.
2026-02-12
HORIBA, Ltd., Board Meeting, Feb 12, 2026. Agenda: To consider to distribute dividends from retained earnings.
2026-01-29
HORIBA, Ltd., 2025 Earnings Call, Feb 13, 2026
2026-01-05
SEMI, SEMICON SEA 2026, May 05, 2026 through May 07, 2026. Venue: MITEC, Kuala Lumpur, Malaysia.
2025-12-27
HORIBA, Ltd. announced that they will report fiscal year 2025 results on Feb 12, 2026
2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 384,495 | 363,991 | 345,733 | 333,081 | 331,735 | 323,592 | 318,994 | 317,369 | 305,758 | 302,173 |
Pretax Income Excl.Unusual Items | 71,877 | 63,116 | 54,678 | 54,225 | 52,830 | 53,432 | 51,632 | 50,170 | 50,272 | 49,389 |
Total Assets | 552,322 | 543,203 | 511,991 | 518,279 | 490,211 | 478,907 | 470,786 | 481,616 | 445,930 | 469,349 |
Total Liabilities | 184,732 | 177,941 | 167,324 | 169,640 | 166,364 | 165,003 | 164,981 | 166,914 | 157,213 | 165,572 |
Cash & Cash Equivalents | 175,784 | 169,311 | 150,862 | 162,339 | 153,824 | 151,452 | 147,950 | 144,272 | 128,217 | 134,237 |
Total Common Equity | 367,543 | 365,221 | 344,627 | 348,602 | 323,826 | 313,887 | 305,788 | 314,688 | 288,702 | 303,760 |
Book Value Per Share (BVPS) | 8,746.54 | 8,691.28 | 8,206.21 | 8,300.85 | 7,710.88 | 7,474.19 | 7,288.91 | 7,489.24 | 6,881.64 | 7,240.55 |
Net Change in Cash | 17,891 | 18,508 | 17,736 | 13,413 | 7,227 | |||||
Capital Expenditure | -27,122 | -25,275 | -20,828 | -18,152 | -10,759 |
As of November 13, 2026, HORIBA published financial results for the third quarter of 2026, having revenues of 101.81B yen and net income of 14.54B yen, representing a sharp 25.2% rise in revenues, along with a significant increase of approximately 76.6% in EPS compared with the same quarter last year. A positive sign is that for the 12th consecutive quarter, the company has demonstrated an increase in its income line compared to the corresponding quarter of the previous year, indicating the company's stability and potential for growth in the future.
Additionally, the EBITDA margin experienced a slight decrease from 26.64% in the corresponding quarter last year to 23.12%. It is important to note that the stock's dividend yield stands at approximately 3%, and it trades at 15.9x times current year's earnings, which is higher than the sector average (P/E 12.3x).